| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT07007559 ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in… |
Trial sites expanded: 32 -> 44 locations |
| 2026-06-05 | NCT07021989 ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma |
date change Primary completion pushed: 2029-03-31 -> 2029-05-31 |
| 2026-06-05 | NCT07021989 ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma |
date change Completion pushed: 2033-10-31 -> 2033-12-31 |
| 2026-05-28 | NCT06459180 A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-27 | NCT07461454 YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer |
Recruitment opened |
| 2026-05-23 | NCT06564844 A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or… |
Trial sites reduced: 99 -> 90 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06908304 | A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in… | Carcinoma, Non-Small -Cell Lung | Recruiting |
| NCT06435429 | A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in… | Metastatic HER2-positive Breast Cancer | Recruiting |
| NCT06081959 | Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer | Metastatic Breast Cancer | Recruiting |
| NCT07461454 | YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer | Locally Advanced or Metastatic Breast Cancer | Recruiting |
| NCT06632327 | Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB… | Resectable Lung Non-Small Cell Carcinoma | Recruiting |
| NCT06519370 | FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or… | Triple Negative Breast Cancer | Active, Not Recruiting |
| NCT04639986 | Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer… | Metastatic Breast Cancer | Active, Not Recruiting |
| NCT07466316 | A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose… | Rhabdomyosarcoma | Not Yet Recruiting |
| NCT06343948 | A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… | HR+HER2- Breast Cancer | Active, Not Recruiting |
| NCT06382142 | A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… | Triple-Negative Breast Cancer | Active, Not Recruiting |
| NCT02486718 | Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best… | Non-Small Cell Lung Cancer | Active, Not Recruiting |
| NCT03456076 | A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in… | Carcinoma, Non-Small-Cell Lung | Active, Not Recruiting |
| NCT04994132 | A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With… | Alveolar Rhabdomyosarcoma | Active, Not Recruiting |
| NCT05104866 | A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of… | Breast Cancer | Active, Not Recruiting |
| NCT06564844 | A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or… | Non-small Cell Lung Cancer | Active, Not Recruiting |
| NCT02567435 | Combination Chemotherapy With or Without Temsirolimus in Treating Patients With… | Alveolar Rhabdomyosarcoma | Active, Not Recruiting |
| NCT06459180 | A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of… | Cervical Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT05999994 | A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children… | Neoplasms | Recruiting |
| NCT03618550 | Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin… | Hodgkin Lymphoma | Recruiting |
| NCT06377566 | A Study of BV-AVD in People With Bulky Hodgkin Lymphoma | Hodgkin Lymphoma | Recruiting |
| NCT07007559 | ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in… | Breast Cancer, Metastatic | Recruiting |
| NCT07420439 | Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung… | Non Small Cell Lung Cancer Metastatic | Not Yet Recruiting |
| NCT07021989 | ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma | Hodgkin Lymphoma, Adult | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT02813135 | European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in… | Pediatric Cancer | Recruiting |
| Not specified | |||
| NCT06576635 | LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC)… | NSCLC | Recruiting |